Table 1.

Patients demographics

Demographics
Patient #	Sex	Age	Primary Location	Stage	FDG Time PI	FMISO Time PI	HPV
1	M	79	Oropharynx	T3N2c	91	171	–
2	M	67	Oropharynx	T3N1	82	193	–
3	M	48	Oropharynx	T1N1	65	181	–
4	M	54	Larynx	T2N2bM0	74	157	–
5	M	62	Oropharynx	T4N2c	131	147	–
6	M	60	Oropharynx	T2N1	83	153	–
7	M	64	Oropharynx	T2N2b	71	166	–
8	M	60	Oropharynx	T4N2c	50	180	–
9	M	62	Oropharynx	T4aN2c	69	196	–
10	M	55	Oropharynx	T2N1	85	115	–
11	M	66	Oropharynx	T1N3	180	155	–
12	M	56	Oropharynx	T3N2c	85	157	–
13	M	47	Oropharynx	T3N1	68	153	–
14	M	57	Oropharynx	T2N2c	75	160	HPV+
15	M	25	Oropharynx	T2N2bM0	85	156	HPV+
16	M	56	Oropharynx	T2N2bM0	63	154	HPV+
17	F	63	Oropharynx	T2N2bM1	80	182	HPV+
18	M	57	Oropharynx	T1N2b	66	148	HPV+
19	M	49	Oropharynx	T2N2b	68	135	HPV−
20	M	58	Oropharynx	T2N2b	77	181	HPV+